About Mitomics
Mitomics is a Healthcare company based in Thunder Bay (Canada) founded in 2010, and was acquired by MDNA Life Sciences in November 2014. Molecular diagnostics are developed using the mitochondrial genome for oncology. Mitomics has raised $2.23 million across 6 funding rounds from investors including MDNA Life Sciences. Its chief executive, as recorded, is Christopher Mitton. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Pan Cancer. Its legal entity is Mitomics Inc.
Company details
Mitomics was founded in 2010 in Thunder Bay, Canada, focusing on biotechnology and molecular diagnostics. Assays were created for detecting cancers such as skin, breast, prostate, and lung through mitochondrial genome analysis. The primary product, Prostate Core Mitomic Test, was designed to assess high-risk prostate tumors missed by biopsies, reducing the need for additional invasive procedures. The company was acquired by MDNA Life Sciences in November 2014.
- Headquarters Thunder Bay, Canada
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website mitomicsinc.com
- Social LinkedIn
- Acquired by MDNA Life Sciences (Nov 2014)
- Legal Name Mitomics Inc.
- Total Equity Funding$2.23M (USD)
in 6 rounds
- Latest Funding Round$2.08M (USD), Series A
Sep 2013
- Investors
- Acquired byMDNA Life Sciences
(Nov 2014)
Funding Insights of Mitomics
Mitomics has successfully raised a total of $2.23M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $2.08 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.23M
- Total Rounds 6
- Last Round Series A — $2.08M
- First Round $766,666
(Dec 2010)
All 6 funding rounds of Mitomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2013 | $2.08M | Series A | – | – | – |
| Mar 2013 | $100,000 | Seed | – | – | – |
| Sep 2011 | $51,115 | Seed | – | – | – |
| Jun 2011 | $25,600 | Debt – Conventional | – | – | – |
| Dec 2010 | $73,530 | Debt – Conventional | – | – | – |
| Dec 2010 | $766,666 | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Mitomics
Mitomics has secured backing from 1 investor. Prominent investors backing the company include MDNA Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Genomic and molecular diagnostics based on mitochondrial genome are provided. | 2001 | mdnalifesciences.com | Jupiter, United States |
Investor details for Mitomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mitomics
1 people are tracked at Mitomics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Christopher Mitton | CEO | Leadership |
Complete people profiles for Mitomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mitomics
4 dated milestones of Mitomics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Mitomics is founded.
- Funding First funding round of $767K.
- Funding Latest funding round, Series A, of $2.1M.
- Exit Acquired by MDNA Life Sciences.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mitomics
Mitomics was founded in 2010.
Mitomics is headquartered in Thunder Bay, Canada. It is registered at Thunder Bay, Ontario, Canada.
Christopher Mitton is the CEO of Mitomics, as recorded in our data.
Mitomics is a funded company, having raised a total of $2.23M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $766.67K, raised on Dec 2010.
Mitomics was founded in 2010 in Thunder Bay, Canada, focusing on biotechnology and molecular diagnostics. Assays were created for detecting cancers such as skin, breast, prostate, and lung through mitochondrial genome analysis. The primary product, Prostate Core Mitomic Test, was designed to assess high-risk prostate tumors missed by biopsies, reducing the need for additional invasive procedures. The company was acquired by MDNA Life Sciences in November 2014.
Mitomics has 1 investor. Key investors include MDNA Life Sciences.
Mitomics operates through Mitomics Inc..
Yes. Mitomics was acquired by MDNA Life Sciences in November 2014.